Stool test could spot stomach cancer before it spreads
NCT ID NCT07312500
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether testing stool (feces) for certain DNA changes and bacteria genes can help find stomach cancer early. Researchers will follow 3000 people, including those with and without cancer, to see how well the test works. The goal is to improve early diagnosis and track if cancer comes back after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC (STOMACH) CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test predict leukemia risk after cancer therapy?
- When to treat? new trial aims to optimize therapy for oligometastatic esophageal and gastric cancer
- New hope for stomach cancer: experimental drug BHB810 enters human trials
- New drug DA-3501 takes on tough cancers in first human trial
- Algerian gastric cancer study aims to map diagnosis and care
- Could a common ALS drug prevent chemotherapy brain fog?